指南与共识免疫规划

儿童HPV疫苗接种:在犹豫不决的家长中,医疗服务提供者的推荐至关重要

Pediatric HPV vaccination: Provider recommendations matter among hesitant parents.
指南 / 共识 · Vaccine · 2024-07-30

该研究基于2022年10月对美国阿肯色州成年人进行的随机数字拨号电话调查数据(N=2201),分析聚焦于报告对HPV疫苗犹豫的9至17岁儿童家长子样本(n=201)。结果显示,32.96%的犹豫家长报告其子女已接种至少一剂HPV疫苗,仅50.93%的犹豫家长收到医疗服务提供者的推荐;收到推荐与儿童HPV疫苗接种的调整比值比为4.67(95%CI[1.89, 11.55]),而提供者未推荐与无提供者之间的接种率无显著差异。结论认为,即使对疫苗犹豫的家长,医疗服务提供者的推荐对促进HPV疫苗接种也很重要。

要点

  • 在疫苗犹豫家长中,32.96%报告其子女已接种至少一剂HPV疫苗。
  • 仅50.93%的疫苗犹豫家长收到医疗服务提供者关于9至17岁子女接种HPV疫苗的推荐。
  • 收到提供者推荐时,儿童HPV疫苗接种的调整OR=4.67(95%CI[1.89, 11.55])。

核心结论

  • 医疗服务提供者的推荐对于促进HPV疫苗接种很重要,即使在疫苗犹豫的家长中也是如此。
  • 需要进一步研究以了解为何儿童HPV疫苗推荐不更频繁或更一致,尤其是在疫苗犹豫人群中。
  • 本研究支持关于犹豫接种者(hesitant adopters)日益增多的研究。

研究设计与样本

  • 研究利用2022年10月通过随机数字拨号收集的阿肯色州成年人电话调查数据(N=2201),对黑人和西班牙裔受访者进行了过度抽样以确保充分代表性。
  • 调查以英语和西班牙语提供。
  • 分析聚焦于报告HPV疫苗犹豫的9至17岁儿童家长子样本(n=201)。
  • 分析包括描述性统计、双变量逻辑回归和采用全信息最大似然估计的多变量逻辑回归。

主要发现

  • 三分之一(32.96%)的疫苗犹豫家长报告其子女已接种至少一剂HPV疫苗。
  • 仅一半(50.93%)的疫苗犹豫家长收到医疗服务提供者关于9至17岁子女接种HPV疫苗的推荐。
  • 当疫苗犹豫家长收到医疗服务提供者的推荐时,儿童HPV疫苗接种的调整比值比是未收到推荐时的四倍(OR=4.67;95%CI[1.89, 11.55])。
  • 对于提供者未推荐HPV疫苗的家长,其儿童HPV疫苗接种与无提供者的情况无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States. HPV-associated diseases are preventable with vaccination, but HPV vaccine coverage remains below other vaccines recommended during childhood and adolescence. We examined correlates of pediatric HPV vaccination among parents who have reported hesitancy toward the HPV vaccine. In addition to sociodemographic correlates, we investigated the relationships between the social process of healthcare provider recommendations and pediatric HPV vaccination. METHODS: We utilized phone survey data (N = 2201) collected in October 2022 via random digit dialing of Arkansan adults-Black and Hispanic respondents were oversampled for adequate representation. The survey was provided in English and Spanish. The analysis focused on a subsample of parents of children ages 9 to 17 years who reported HPV vaccine hesitancy (n = 201). Analyses include descriptive statistics, bivariate logistic regression, and multivariate logistic regression with Full Information Maximum Likelihood estimation. RESULTS: A third (32.96%) of vaccine-hesitant parents reported their child(ren) had received at least one dose of the HPV vaccine. Only half (50.93%) of vaccine-hesitant parents received a healthcare provider recommendation to vaccinate their child(ren) between the ages of 9 and 17 against HPV. Adjusted odds of pediatric HPV vaccination were four times greater when vaccine-hesitant parents received a healthcare provider's recommendation (OR = 4.67; 95% CI[1.89, 11.55]) compared to when they had not. Pediatric HPV vaccination for parents whose provider did not recommend the HPV vaccine was not significantly different from those with no provider. CONCLUSION: Healthcare provider recommendations are important for promoting HPV vaccination even among parents who are vaccine hesitant. Additional research is needed to understand why pediatric HPV vaccine recommendations are not made more often or consistently, particularly among vaccine-hesitant populations. This study demonstrates support for the growing body of research on hesitant adopters.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Willis DE, Moore R, Selig JP, et al. Pediatric HPV vaccination: Provider recommendations matter among hesitant parents. Vaccine. 2024. PMID: 39079809. doi:10.1016/j.vaccine.2024.126166

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。